Starry(SH:603520)2023-10-30 16:00Financial Performance - The company's revenue for Q3 2023 reached ¥547,023,447.21, representing a year-on-year increase of 25.87%[5] - Net profit attributable to shareholders was ¥4,041,613.47, a significant increase of 109.07% compared to the same period last year[5] - The net profit after deducting non-recurring gains and losses was ¥733,482.73, up 101.55% year-on-year[5] - The basic earnings per share for the quarter was ¥0.01, reflecting a 107.69% increase compared to the previous year[6] - The net profit attributable to shareholders for the reporting period was 109.07 million, primarily due to increased sales scale and gross profit[11] - The net profit attributable to shareholders after deducting non-recurring gains and losses for the reporting period was 101.55 million, driven by expanded sales scale[11] - The basic earnings per share for the reporting period was 107.69, reflecting the increase in sales scale and gross profit[11] - The total profit for Q3 2023 was CNY 41,320,792.35, an increase from CNY 37,896,443.92 in the same period last year, reflecting a growth of 11.2%[23] - The operating profit for Q3 2023 was CNY 43,520,019.11, slightly up from CNY 43,261,283.24 in Q3 2022, indicating a marginal increase of 0.6%[23] - The total operating revenue for the first three quarters of 2023 reached RMB 1,630,901,795.41, an increase from RMB 1,377,075,729.25 in the same period of 2022, representing a growth of approximately 18.4%[22] Assets and Liabilities - Total assets at the end of the reporting period amounted to ¥5,700,495,649.48, an increase of 7.51% from the end of the previous year[6] - Current assets totaled RMB 2,481,474,829.63, up from RMB 2,171,638,504.78 at the end of 2022, indicating a growth of approximately 14.2%[18] - The company's cash and cash equivalents increased to RMB 803,991,672.25 from RMB 661,563,157.89, marking a rise of around 21.5%[18] - Total liabilities reached RMB 3,936,354,678.85, compared to RMB 3,530,966,127.81 at the end of 2022, representing an increase of approximately 11.5%[20] - The company's equity attributable to shareholders decreased slightly to RMB 1,757,956,780.51 from RMB 1,765,240,118.24, indicating a decline of about 0.2%[20] Cash Flow - Cash flow from operating activities for the year-to-date was ¥51,517,167.80, showing a 136.97% increase[6] - The cash flow from operating activities for the first nine months of 2023 was CNY 51,517,167.80, a significant recovery from a negative cash flow of CNY -139,367,076.42 in the same period last year[26] - The cash inflow from operating activities for Q3 2023 totaled CNY 1,761,448,038.50, compared to CNY 1,590,851,368.00 in Q3 2022, indicating an increase of 10.7%[27] - Cash inflow from financing activities totaled approximately ¥2.75 billion, an increase from ¥1.74 billion in the previous year, representing a growth of 57.9%[28] - Cash outflow from financing activities was approximately ¥2.47 billion, up from ¥1.40 billion, indicating a rise of 76.1%[28] - Net cash flow from financing activities was approximately ¥275.94 million, a decrease of 18.2% compared to ¥338.15 million in the previous year[28] - The net increase in cash and cash equivalents was approximately ¥106.94 million, contrasting with a decrease of ¥48.13 million in the same period last year[28] - The ending balance of cash and cash equivalents reached approximately ¥685.70 million, up from ¥566.14 million year-over-year, reflecting an increase of 21.1%[28] Shareholder Information - The total number of common shareholders at the end of the reporting period was 34,863[14] - The largest shareholder, Hu Jian, holds 61,740,000 shares, representing 18.03% of the total shares, with 30,800,000 shares pledged[14] - The second-largest shareholder, Hu Jinsheng, holds 60,096,168 shares, representing 17.55% of the total shares, with 33,245,000 shares pledged[14] Inventory and Expenses - The company reported a significant increase in inventory by 44.87%, attributed to rising raw material costs and increased stockpiling[10] - The company recorded an increase in inventory impairment losses of 1,743.26 million during the reporting period[11] - Research and development expenses for Q3 2023 amounted to CNY 103,546,680.20, up from CNY 95,473,436.89 in Q3 2022, marking an increase of 8.8%[23] - The total operating costs for Q3 2023 were CNY 1,593,036,730.90, compared to CNY 1,389,191,306.23 in Q3 2022, representing an increase of 14.7%[23] Government Subsidies and Non-Recurring Gains - Non-recurring gains totaled ¥3,308,130.74 for the quarter, with government subsidies contributing significantly to this figure[9] - The company experienced a decrease in government subsidies received, resulting in other income dropping by 32.59 million[11]